221 related articles for article (PubMed ID: 16181262)
1. The benefits of early vasoactive therapy in the treatment of acute decompensated heart failure.
Albert NM
J Am Acad Nurse Pract; 2005 Oct; 17(10):403-10. PubMed ID: 16181262
[TBL] [Abstract][Full Text] [Related]
2. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the acute decompensation of heart failure: efficacy and pharmacoeconomics of early initiation of therapy in the emergency department.
Emerman CL
Rev Cardiovasc Med; 2003; 4 Suppl 7():S13-20. PubMed ID: 14668696
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
Saltzberg MT
Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
[TBL] [Abstract][Full Text] [Related]
5. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
[TBL] [Abstract][Full Text] [Related]
6. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
[TBL] [Abstract][Full Text] [Related]
7. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
[TBL] [Abstract][Full Text] [Related]
8. Standardizing care for acute decompensated heart failure in a large megatrial: the approach for the Acute Studies of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure (ASCEND-HF).
Ezekowitz JA; Hernandez AF; Starling RC; Yancy CW; Massie B; Hill JA; Krum H; Diaz R; Ponikowski P; Metra M; Howlett JG; Gennevois D; O'Connor CM; Califf RM; Fonarow GC
Am Heart J; 2009 Feb; 157(2):219-28. PubMed ID: 19185628
[TBL] [Abstract][Full Text] [Related]
9. Early vasoactive drugs improve heart failure outcomes.
Peacock WF; Emerman C; Costanzo MR; Diercks DB; Lopatin M; Fonarow GC
Congest Heart Fail; 2009; 15(6):256-64. PubMed ID: 19925503
[TBL] [Abstract][Full Text] [Related]
10. Critical review and recommendations for nesiritide use in the emergency department.
Collins SP; Hinckley WR; Storrow AB
J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453
[TBL] [Abstract][Full Text] [Related]
11. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
[TBL] [Abstract][Full Text] [Related]
12. Optimizing outcomes in the patient with acute decompensated heart failure.
Mehra MR
Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
[TBL] [Abstract][Full Text] [Related]
13. Acute decompensated heart failure: best evidence and current practice.
Mehta R; Feldman D
Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
[TBL] [Abstract][Full Text] [Related]
14. Hospital policies for treatment of acute decompensated heart failure.
Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
[TBL] [Abstract][Full Text] [Related]
15. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
Noviasky JA
Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
[TBL] [Abstract][Full Text] [Related]
16. Nesiritide: the latest drug for treating heart failure.
Fontana D
Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
[No Abstract] [Full Text] [Related]
17. Optimizing treatment of chronic decompensated heart failure in the outpatient setting.
Silver MA
Rev Cardiovasc Med; 2004; 5 Suppl 4():S28-36. PubMed ID: 15627916
[TBL] [Abstract][Full Text] [Related]
18. Acute decompensated heart failure: challenges and opportunities.
Fonarow GC
Rev Cardiovasc Med; 2007; 8 Suppl 5():S3-12. PubMed ID: 18192951
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic stabilization and management of acute heart failure syndromes in the emergency department.
Kirk JD; Parissis JT; Filippatos G
Heart Fail Clin; 2009 Jan; 5(1):43-54, vi. PubMed ID: 19026385
[TBL] [Abstract][Full Text] [Related]
20. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
Heywood JT; Khan TA
Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
